Lenovo Unveils Pioneering AI-Driven Devices at Lenovo Innovation World 2024

5.9.2024 17:00:00 CEST | Business Wire | Press release

Lenovo also announced that it has extended its partnership with Formula 1®

Lenovo™, a global leader in technology innovation, announced its latest advancements at Lenovo Innovation World 2024, unveiling a series of AI PC devices, including ThinkPad™, ThinkBook™, Yoga™, and IdeaPad™ laptops, designed to transform both enterprise and consumer user experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905372293/en/

(Photo: Business Wire)

AI PC Era

AI PCs are set to revolutionize computing as their relevance grows, with 60% of PCs shipped by 2027 anticipated to be AI-capable. Lenovo’s AI PCs are at the forefront of this transformation, leveraging natural interactions, personalized large language models, and advanced computing architectures. These innovations make computing more personal by tailoring experiences to individual users, more productive by enhancing workflow efficiency, and more protected by integrating robust security features into AI-driven systems.

"At Lenovo, we are committed to pushing the boundaries of innovation and bringing AI-powered technology to everyone. Our latest AI PCs, including the groundbreaking Aura Edition series, represent a significant leap forward in delivering highly personalized, productive, and protected computing experiences,” said Luca Rossi, President of Lenovo Intelligent Devices Group. “Through close collaboration with industry leaders, we are redefining what’s possible with AI, ensuring that our customers can harness the full potential of these transformative technologies to drive productivity, creativity, and growth in the AI era."

Powering Business Users in the AI Era

In the commercial segment for business users, Lenovo introduced the ThinkPad X1 Carbon Gen 13 Aura Edition, a cutting-edge business laptop co-developed with Intel. This device features Intel® Core™ Ultra technology, offering unparalleled AI capabilities and a user-centric design. The Lenovo Aura Edition series include innovative features such as Smart Modes, which intuitively adapt performance and AI capabilities to user activities, and Smart Share, enabling seamless AI-driven image sharing between devices. Smart Care provides 24/7 real-time support, ensuring users receive the assistance they need. With its advanced AI capabilities, the ThinkPad X1 Carbon Gen 13 Aura Edition redefines productivity, security, and user interaction in a lightweight, premium build.

Alongside it, Lenovo presented the ThinkPad T14s Gen 6 AMD and the ThinkBook 16 Gen 7+ powered by AMD Ryzen™ AI processors, showcasing exceptional multitasking, creative expression, and energy efficiency. Additionally, Lenovo revealed the ThinkBook 16 Gen 7, equipped with the Snapdragon® X Plus 8-core processor, bringing robust AI performance to small and medium-sized businesses.

Lenovo also announced AI PC Fast Start, a solution designed to help organizations swiftly transition to AI-ready devices, maximizing ROI through AI-powered advisory and simplified deployment. Backed by Lenovo's award-winning support, these services accelerate AI adoption and ensure seamless implementation.

Lenovo showcased the Lenovo Auto Twist AI PC, a proof-of-concept that redefines user interaction with intelligent automation and AI. This device features an industry-first auto-twist design, integrating AI-powered flexibility, smart interaction, and enhanced security to create a seamless and ergonomic computing experience.

Empowering Consumers with AI Technology

For consumers, Lenovo introduced several distinct laptops. The Lenovo Yoga Slim 7i Aura Edition (15”, 9), developed in collaboration with Intel, represents the pinnacle of premium design and innovative technology. This laptop includes the Lenovo Aura Edition range of features tailored to enhance user experience, including Smart Modes, Smart Share and Smart Care. Powered by Intel's Core Ultra processor with high-performance integrated graphics, and an optional 2.8K OLED touchscreen delivering stunning visuals, the laptop is designed for demanding tasks.

The LenovoYoga Pro 7 (14”, 9), powered by the AMD Ryzen AI 9 processor with 50 TOPS neural processing unit (NPU) performance, is tailored for content creators and professionals who demand powerful multitasking and creative capabilities. It comes equipped with Lenovo X Power features to improve performance and efficiency. The Yoga Pro 7 also features a 14.5” PureSight Pro OLED display with stunning color accuracy and sharpness, providing an immersive visual experience for design and media work.

The Lenovo IdeaPad Slim 5x (14”, 9) and IdeaPad 5x 2-in-1 (14”, 9) further expand Lenovo’s AI offerings for mainstream users, blending sleek design with powerful performance. These devices, powered by Snapdragon X Plus 8-core processors, offer enhanced AI-driven productivity and versatile form factors, making them suitable for a wide range of user needs.

Lenovo further expands its IdeaPad laptop portfolio with the IdeaPad Slim 5 15" and 13" models, both of which are powered by AMD Ryzen 7000 Series Processors. These laptops offer robust performance for multitasking and demanding applications, and feature high quality displays for creative work and media consumption. Both models boast sleek, ultra-thin, and light designs, making them ideal for professionals and students alike.

Lenovo also showcases the Lenovo Creator Zone, an AI-powered software suite with Stable Diffusion 3 model, that enables creators to use natural language and reference images to generate and edit visual content, streamlining the creative process. The suite is initially available on the Lenovo Yoga Pro 9i, with support for additional Lenovo Yoga devices to follow.

Global Retail Design Language

Lenovo’s product showcase illustrated its innovative new Global Retail Design Language, a strategic initiative designed to transform the customer experience across all physical retail formats. This new design language, shown through the tables in the showcase area at Lenovo Innovation World, accentuates a cohesive and immersive brand presence, ensuring uniformity and consistency in Lenovo's global retail operations.

Built on five core principles designed to echo Lenovo’s recognizable visual identity through a premium feel using natural and more sustainable materials that exhibit warm minimalism and emphasizes Lenovo’s ecosystem of innovative products. By transforming the customer journey with engaging environments, interactive touchpoints, and personalized service, Lenovo aims to create an inspiring and memorable experience for every customer who engage with Lenovo in retail locations.

Lenovo Becomes Global Partner of Formula 1^®

Lenovo is set to become Global Partner of Formula 1 starting in 2025, while Motorola will serve as Global Smartphone Partner. This multi-year renewal will see Lenovo continue to provide cutting-edge technology, including High-Performance Computing solutions, servers, and edge devices, to support F1’s operations both at the track and remotely. Lenovo will also be the title sponsor of two races per season and increase its trackside branding alongside Motorola. The partnership highlights Lenovo’s commitment to innovation and sustainability, with initiatives like Lenovo’s Asset Recovery Service contributing to F1’s sustainability goals. Together, Lenovo and F1 will explore next-generation technologies such as AI PCs, AI-enabled Motorola smartphones and AR/VR solutions, further enhancing the sport’s global reach and fan engagement.

Lenovo Innovation World 2024

For more information, visit Lenovo’s Innovation World homepage or reference the announcements below:

About Lenovo

Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905372293/en/

Contacts

Adrian Horne, adrianhorne@lenovo.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom